Impact of Comorbidities on Patients With Waldenström Macroglobulinemia in Taiwan: A Multicenter Study
Real-world WM data were used to validate the prognostic value of IPSSWM and revised IPSSWM in an Asian population. High comorbidity burden was associated with a poor survival, and the need for HBV prophylaxis was disclosed in patients with a history of HBV infection.
Authors
- Chao‐Hung Wei (ORCID: https://orcid.org/0000-0003-4625-0534)
- Ta-Chuan Yu (ORCID: https://orcid.org/0000-0003-4894-9306)
- Yi-Lin Tuan (ORCID: https://orcid.org/0009-0006-0556-515X)
- Junwei Gao (ORCID: https://orcid.org/0000-0003-1944-144X)
- Tai‐Chung Huang (ORCID: https://orcid.org/0000-0002-1625-7295)
- Yu-Sung Chang (ORCID: https://orcid.org/0009-0000-4571-3328)
- Po-Ju Chiu
Institutions
- National Taiwan University Hospital (TW)
- National Yunlin University of Science and Technology (TW)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1200/go-24-00576
- Citations
- 1
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 1.63